After 3 weeks treatment, we observed leukemic cytoreduction (Fig. 5b) and decreased BM TNFα levels (Fig. 5c) in AC220-treated AML mice compared with vehicle-treated controls. This evidence concerns the gene TNF and acute myeloid leukemia.